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DNA nanotechnology has established approaches for designing
programmable and precisely controlled nanoscale architectures
through specific Watson−Crick base-pairing, molecular plasticity,
and intermolecular connectivity. In particular, superior control
over DNA origami structures could be beneficial for biomedical
applications, including biosensing, in vivo imaging, and drug and
gene delivery. However, protecting DNA origami structures in
complex biological fluids while preserving their structural charac-
teristics remains a major challenge for enabling these applications.
Here, we developed a class of structurally well-defined peptoids to
protect DNA origamis in ionic and bioactive conditions and system-
atically explored the effects of peptoid architecture and sequence
dependency on DNA origami stability. The applicability of this ap-
proach for drug delivery, bioimaging, and cell targeting was also
demonstrated. A series of peptoids (PE1–9) with two types of ar-
chitectures, termed as “brush” and “block,” were built from posi-
tively charged monomers and neutral oligo-ethyleneoxy monomers,
where certain designs were found to greatly enhance the stability
of DNA origami. Through experimental and molecular dynamics stud-
ies, we demonstrated the role of sequence-dependent electrostatic
interactions of peptoids with the DNA backbone. We showed that
octahedral DNA origamis coated with peptoid (PE2) can be used as
carriers for anticancer drug and protein, where the peptoid modu-
lated the rate of drug release and prolonged protein stability against
proteolytic hydrolysis. Finally, we synthesized two alkyne-modified
peptoids (PE8 and PE9), conjugated with fluorophore and antibody,
to make stable DNA origamis with imaging and cell-targeting capa-
bilities. Our results demonstrate an approach toward functional and
physiologically stable DNA origami for biomedical applications.
DNA nanotechnology | peptoid | molecular coating
DNA nanotechnology has advanced in programing the self-assembly of synthetic oligonucleotides into precisely pre-
scribed molecular and nanoscale constructs with targeted to-
pologies and spatial configurations (1–4). In applications, from
electronics and photonics to biology and nanomedicine, DNA
nanostructures with the appropriate attachment chemistries have
been employed to direct controlled assembly of functional guest
elements such as (bio)molecules and inorganic nanoparticles
(NPs) (5–12). For biomedical functionalities, DNA origami has
the potential to act as smart drug-delivery vehicles and bio-
molecular devices at the cellular level (13–17). In particular, DNA
origami designed with controlled topology, biocompatibility, and
responsiveness toward other biomolecules (e.g., proteins, lipo-
somes, DNAs, and RNAs) provides a tailorable platform for en-
gineering molecular interface and augmenting functionalities of
the hybrid bio/nano system. For example, DNA-based logic-gated
nanorobots for modulating cell signaling (18, 19) and DNA origami
carriers loaded with small interfering RNA (20), CpG sequences
(21), enzymes (22, 23), and therapeutic drugs (24–26) were recently
reported.
However, biomedical applications of DNA origamis are often
incompatible with the high content of magnesium ions (10 to
20 mM) that are typically required for DNA origami self-assembly
and long-term stability (27). Thus, the poor structural integrity of
DNA origamis in physiological fluids, which typically contain ∼1 mM
Mg2+, is one of the key challenges for establishing a therapeutic
platform based on DNA origamis (28). Moreover, as the presence of
enzymes (e.g., nucleases) and variation of solution pH can affect or
even damage the DNA origami superstructures (28–30), it is crucial
to seek new strategies to maintain their structural integrities and
biological functions to facilitate broad biomedical applications.
Two major approaches have been investigated in previous studies
to address these challenges. In the first approach, highly dense and
stiff DNA origami structures, including the wireframed structures
with polyhedral mesh (31, 32) and multiduplex DNA edges (33, 34),
were explored to reduce unfolding and degradation of origamis
caused by solution environments. Introduction of covalent cross-
links to interlock the adjacent duplexes were also reported (29,
35, 36). For example, Gerling et al. (35) placed proximal thymidines
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to covalently link termini and cross-over sites or create new inter-
helical connections via ultraviolet irradiation, allowing high thermal
and ionic stabilities. Cassinelli et al. (36) applied click chemistry to
catenate DNA strands, which enabled stable structures at low ionic
strengths. The second approach involves noncovalent coating of
DNA origamis with polyethylene glycol (PEG)-conjugated cationic
polymers to stabilize against low Mg2+ contents in solution and to
slow down nuclease degradation (37–39). Virus capsid proteins (40)
and protein-cationic dendron conjugates (41) have also been used
as coating layers to protect origamis against nucleases and enhance
the transfection efficiency. In these approaches, electrostatic in-
teractions between the positively charged moieties and the nega-
tively charged DNA molecules are the key driving force for the
adsorption of polycations onto DNA backbones. These localized
polycations are thought to increase DNA stability by suppressing
the interstrand repulsive force originating from the phosphate
groups. Despite the progress in DNA origami protection strategies,
it remains challenging to create molecularly precise and tunable
protective coatings. This is critical in order to preserve origamis
under a variety of biomedically relevant conditions that neither
affect the structural integrity of origamis nor mask its shape and
features. The objective of this study is to establish such a rational
and tunable platform for designed molecular coatings of origamis
that allow structural stabilization, chemical modularity, and bi-
ological versatility and to verify their efficacy in different biological
environments.
In this work, we demonstrate that peptoid-based coating
provides a tunable platform for protecting DNA nanostructures
in a broad range of bioactive environments. Peptoids, comprising
N-substituted glycines, are an emerging class of peptidomimetic
molecules that offer biocompatibility, low-cost synthesis, high
chemical flexibility, and designable sequences and performances
(42–44). In a recent study, Xuan et al. (45) demonstrated that
peptoid architectures could be engineered at the atomic level,
resulting in a variety of atomically defined structural arrange-
ments. Compared to peptides, peptoids possess high conforma-
tional flexibility and confer a high degree of resistance to
proteolytic degradation (44, 46), due to the side chains located on
the nitrogen of the amide backbone instead of the α‐carbon. These
tunable properties, as well as their intrinsic biocompatibility, offer
an attractive property for drug/gene delivery and cellular-imaging
applications (47–50).
We focus this study on the investigation of a capability of
peptoids with different architectures to protect DNA origamis in
physiological conditions. The three-dimensional (3D) wireframed
octahedra-shaped DNA origami (OC) was selected for this study
for its mechanical stability, as well as the ability to carry nanoscale
cargo. We exploit sequence-defined peptoids as structurally tun-
able polycations for the stabilization of OCs in bioactive solutions.
The designed OC presents a rigid 3D structure that comprises six-
duplex bundles at each edge (edge length ∼ 29 nm) connected by
the single-stranded M13mp18 DNA scaffold (Fig. 1B). This
structure has been reconstructed from single-particle electron
microscopy and applied to the creation of low-dimensional and 3D
DNA–NP framework (51, 52). The frame design is also highly
suitable for the immobilization of biomolecules and drugs of a
range of sizes for biomedical applications due to the ability to de-
sign such structures with targeted sizes, affinities, and molecular-
transport properties.
Here, we show that the design of peptoid sequences is key to
mediating controlled peptoid–DNA interactions (schematic in
Fig. 1C), the result of which leads to various protective effects in
ionic and bioactive solutions and the ability to tailor DNA ori-
gami coatings. The developed strategy of peptoid coating is
further explored in applications of the 3D DNA origami for drug
release, proteolytic resistance, bioimaging, and targeted delivery.
This work provides a platform for the stabilization of DNA
origami structures based on peptoid–DNA interactions and pro-
vides molecular-level insights for expanding DNA origami use in
drug/gene delivery and nanomedicine applications.
Results and Discussion
To protect DNA origami structures by surface coating with
peptoids, we designed peptoid sequences with two types of mono-
mers per chain, where one facilitated electrostatic complexation
with the nucleic acids (i.e., positively charged motifs) and the other
created surface passivation via hydrophilic PEG-like motifs. Fur-
thermore, two types of polycationic peptoids were designed by
varying the composition and spatial distribution to enable multi-
valent peptoid–DNA interactions and compact coating (Fig. 1A and
SI Appendix, Fig. S1). In the brush-type peptoids (PE1–3), positively
Fig. 1. Peptoids with different molecular architectures for DNA origami protection. (A) Chemical structures of peptoids designed to protect 3D OCs. PE1, PE2,
and PE3 represent brush-type peptoids; PE4 and PE5 are block-type peptoids. (B) TEM image and schematic view (Inset) of the OC structure. (Scale bar, 50 nm.)
(C) Schematic view showing the different surface coatings of the two types (“brush” and “block”) of peptoids on OCs proposed in this work, which results in
varied protection effects.
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charged N-(2-aminoethyl)glycine (Nae) and neutral N-2-(2-(2-
methoxyethoxy)ethoxy)ethylglycine (Nte) moieties were assem-
bled alternately. In the block-type peptoids (PE4–5), Nae and Nte
were clustered together to form “blocks” of the repeating units.
These polycationic peptoids were designed to interact electro-
statically to the anionic phosphate backbone of the DNA and
compensate charge repulsions between DNA strands. As a control
experiment, brush-type (PE6) and block-type (PE7) peptoids with
Nae substituted by similarly sized, but neutral, monomer N-(2-
methoxyethyl)glycine (Nme) were studied. Meanwhile, a highly
solvated and unstructured domain by the incorporation of neutral
Nte oligomers was designed to preserve DNA origami structures
during the peptoid–DNA electrostatic interactions. The ether side
chain, like in the Nte monomers, has been shown in previous
peptoid studies to exhibit antifouling and surface passivation
properties. That can prevent surface adsorption of biomolecules in
physiological environments and inhibit enzymatic degradation of
DNA origamis due to proteases and nucleases (44, 46, 53, 54).
In this paper, the binding between a single-duplex DNA and
peptoids was first studied by experimental methods and molecular
dynamics (MD) simulations to elucidate the effect of peptoids of
different designs on a duplex. The observed influence of peptoid
architecture and sequence on the enhanced stability of single
duplexes were further exploited to stabilize 3D OCs in physio-
logical solutions. This includes the depletion of magnesium ions
(Mg2+), the presence of nuclease, and the addition of cell-culture
media. The functionality of peptoid-stabilized OCs was also ex-
plored, where controlled release of an anticancer drug and tryptic
digestion of proteins encapsulated in OC nanostructures were
studied. Finally, alkyne-modified peptoids (PE8 and PE9) were
used to conjugate functional biomolecules and present them on
the surface of peptoid-stabilized OCs.
The effect of the two types (i.e., brush and block) of peptoid
architectures on stabilizing a single-duplex DNA (double-stranded
DNA [dsDNA]) was investigated by real-time SYBR Green I
(SG) fluorescence assay. SG is known to have a stronger affinity
toward dsDNA than to single-stranded DNA (ssDNA) due to the
favored intercalation between base pairs and the increased sta-
bility of the SG/dsDNA complex (55, 56). The fluorescence assay
is based on the enhanced SG fluorescence in complex with
dsDNA, which originates from the dampening of its intra-
molecular motion (55, 56). Here, a 15-base-pair dsDNA with a
melting temperature (Tm) of ∼44 °C was designed to study dsDNA
stability in the presence of peptoids at varied molar ratios of
peptoid amines to phosphate groups of the DNA (i.e., N/P). In the
experimental setup, the temperature was raised from 37 °C to
85 °C and equilibrated at every 1 °C step for 5 min. At all mea-
sured temperatures (≥40 °C), fluorescence signals of SG/dsDNA
complexes were observed to be higher in the presence of peptoids,
indicating an enhanced stability of DNA base-pairing (Fig. 2A and
SI Appendix, Fig. S2). The increase of fluorescence signal can be
related to the association of SG with dsDNA (55), since no signal
was observed when SG was mixed with peptoids only (SI Appendix,
Fig. S3). Tm of dsDNA/peptoid complexes was presented by the
derivative of fluorescence intensities and plotted against temper-
ature. As shown in Fig. 2 B and D and SI Appendix, Fig. S2,
depending on the amount of peptoid added, Tm of the dsDNA
increased modestly from 1 °C to 6 °C. Among the sequences, PE2
exhibited the highest performance in raising Tm of the dsDNA,
where the Tm shifted from 44 °C to 50 °C as the N/P increased
from 0.125 to 8 (Fig. 2 C and D). Moreover, brush-type peptoids
were observed to confer higher stability of the dsDNA compared to
block-type peptoids, where Tm (dsDNA/PE2)> Tm (dsDNA/PE1)>
Tm (dsDNA/PE4) and Tm (dsDNA/PE3) > Tm (dsDNA/PE5) (Fig.
2 A and B).
In the previous study, it was shown that polycationic polymers
and lipids often cause DNA to form polyplexes due to charge
neutralization. Such aggregated structures can significantly quench
DNA-binding fluorophores (57). Here, the hydrophilic Nte olig-
omers in the peptoid sequences were designed to inhibit DNA
condensation and polyplex formation. We investigated the effect
using PE2, which succeeded in raising the Tm of dsDNA among
the studied peptoids. Indeed, the fluorescence of SG intercalated
inside the dsDNA remained unchanged after the addition of PE2
at room temperature (25 °C) (SI Appendix, Fig. S4). This was
confirmed by agarose gel electrophoresis (AGE), where no ag-
gregation of dsDNA/PE2 was noted at N/P from 0.125 to 8 (SI
Appendix, Fig. S5). These indicated that the peptoid–dsDNA in-
teractions did not induce DNA condensation at the studied
N/P regimes.
Explicit solvent MD simulations were performed to reveal the
binding mechanisms of peptoids of brush and block architectures
with dsDNA in solution (Fig. 3 A and B and SI Appendix, Fig. S6
and Table S1). Following the experimental findings from the
fluorescence assay (Fig. 2A), we selected the distinct brush-type
PE1 and block-type PE4 as representative peptoid models to
study the peptoid–dsDNA interactions at N/P of 0.25 using MD
simulations. The simulations were performed at corresponding
experimental conditions in neutral pH (Materials and Methods).
As shown in SI Appendix, Table S1, the simulations showed
strong binding affinities of both types of peptoids to dsDNA, of
which PE1 and PE4 exhibited persistent contacts (cutoff = 4 Å)
for 98.2% and 98.7% of the total simulation time, respectively.
The peptoids experienced almost immediate binding to the
dsDNA, regardless of their starting structures in the simulations.
This strong attraction was due to the electrostatic attractive forces
between the positively charged Nae residues of the peptoids and
negatively charged phosphate groups of the DNA backbone.
Despite the comparable strong binding, PE1 and PE4 exhibited
distinct differences in the binding mechanisms to dsDNA. Brush-
type PE1 demonstrated persistent interactions (∼98% of the total
contact time) with DNA via both the Nae and Nte motifs, where at
least 58% (Nae) and 61% (Nte) of the time, three or more resi-
dues were in close contact with the dsDNA. In addition, the
“brush” arrangement facilitated PE1 to spread across (“coat”) the
DNA backbone, where it interacted with both major and minor
Fig. 2. Fluorescence assay monitoring peptoid-stabilized duplex DNA
(dsDNA). Real-time SG fluorescence assay of a 15-bp dsDNA (500 μM) in the
presence of peptoids at different ratios of peptoid amines to phosphate
groups of the DNA (N/P) is shown. The fluorescence intensities of dsDNA/
peptoid complexes at N/P of 4 (A and B) and dsDNA/PE2 complexes at dif-
ferent N/P (C and D) are plotted against the increasing temperature. In B and
D, derivatives of fluorescence intensities representing the melting temper-
ature (Tm) of dsDNA are plotted against the increasing temperature.
Wang et al. PNAS | March 24, 2020 | vol. 117 | no. 12 | 6341
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grooves concurrently (48.8% of the total contact time). Preferred
binding toward the minor groove (28.5%) exclusively over the
major groove (6.1%) of the dsDNA was also observed.
In contrast, the block-type peptoid PE4 dominated binding to
dsDNA via the Nae moieties (∼100% of the total contact time),
where four or more Nae residues were in close contact with the
dsDNA for more than 85% of the time. Meanwhile, the Nte
moieties exhibited significantly less persistent interactions with
DNA, where only the closest two Nte residues were involved in
binding for 55% of the total contact time. In addition, the
“block-like” arrangement facilitated the Nte end of PE4 to be
solvent exposed, and, therefore, PE4 was observed to embed in
either the major (39.6%) or minor (24%) grooves of the dsDNA,
while simultaneous interactions with both major and minor
grooves (18.5%) were less favored. As expected, PE1 formed a
larger contact area with dsDNA (2.88 ± 1.11 nm2) compared to
PE4 (2.54 ± 1.05 nm2). However, the average solvent-accessible
surface area of PE4 (17.81 ± 1.64 nm2) was lower than that of
PE1 (18.82 ± 1.47 nm2), due to the more compact structure
adopted by PE4 compared to the elongated PE1 while being
bound to DNA (SI Appendix, Table S1). Interestingly, the MD
simulations showed the PE1 structure to be more flexible and
dynamic while interacting with the dsDNA compared to PE4,
which was frequently restrained due to the embedding of the Nae
moieties within the DNA grooves (demonstrated by the larger
occupancy volume areas adopted by PE4 compared to PE1 in
Fig. 3 A and B).
We propose that water plays an important role in the binding
phenomena of the different peptoid architectures with dsDNA.
The structural organization of water surrounding the pristine
dsDNA and the dsDNA/peptoid complex was investigated by
radial distribution functions (RDFs). Fig. 3 C–F show a higher
density of water molecules surrounding AT base pairs versus GC
base pairs, with notable preference for the AT base pairs within
the minor grooves. The higher solvation of the minor groove, vis-
à-vis the major groove of DNA, was reported (58). Interestingly,
the binding of PE4 contributed to significant expulsion of water
from the dsDNA, with the most evident reduction in water
density at the minor grooves of the AT base pairs and major
grooves of the GC base pairs. We propose that this was due to
the block-like arrangement of PE4, where the “block,” com-
prising osmotic ethylene glycol residues could alter the sur-
rounding dielectric constant, resulting in effective displacement
of water molecules from the DNA structure (59, 60). On the
other hand, PE1 was observed to have the least effect on the
structuring of water surrounding the dsDNA, suggesting that
such a “brush-like” arrangement of PE1 did not impact the water
uptake by dsDNA. Thus, we propose that water can facilitate the
interactions of the polar Nte moieties to achieve a close (albeit
dynamic) binding and larger contact area with the dsDNA. Since
it is known that DNA hydration is directly related to the stability
of duplex formation, specifically through Watson−Crick base
pairs (61), the observed differences in water structuring and
binding mechanisms of PE1 and PE4 to dsDNA play important
roles in the stability of dsDNA. Thus, the simulations are in a
close correspondence with the results obtained from the SG
fluorescence assays (Fig. 2), and such observations can be ex-
tended to elucidate how peptoids bind to DNA.
Guided by the experimental and simulation studies on the
effect of peptoid design toward interactions with DNA, we in-
vestigated the structural stability of OCs coated by peptoids. As
shown in SI Appendix, Fig. S7, transmission electron microscopic
(TEM) imaging showed that the morphology of OCs was main-
tained when N/P was below 0.5. Higher N/P could lead to an
aggregated structure. This was improved by increasing the
number of Nte residues, of which PE2 ((Nae–Nte)12) and PE3
((Nae–Nte–Nme–Nte)6) OCs exhibited higher structural in-
tegrity than PE1 ((Nae–Nte)6). Similarly, increasing the num-
ber of Nte residues in the block-type peptoids, PE4 (Nae6–Nte6)
and PE5 (Nae6–Nte12), to 16 Nte residues enabled more stable
OC structures (SI Appendix, Figs. S7 and S8). This suggests that
incorporation of the hydrophilic Nte motifs promotes a stabili-
zation of DNA origami during polycation–DNA charge neu-
tralization. It is noteworthy that the OC structure is composed of
∼120 dsDNA fragments, and, thus, not only does the peptoid
coating (i.e., PE2) stabilize the origami structure by maintaining
its 3D configuration, but it may facilitate a base-paring of indi-
vidual dsDNA fragments (Fig. 2). An SG assay was performed
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on OC/peptoid (N/P: 0.125) to confirm this effect, where OC/
PE2 exhibited a clear Tm shift from 48 °C to 52 °C (SI Appendix,
Fig. S9).
On the other hand, PE6 and PE7 peptoids, where the posi-
tively charged Nae residues were substituted by neutral Nme
residues on the peptoid backbone, exhibited no obvious struc-
tural changes at even higher N/P (i.e., 0.5, 1, and 2; SI Appendix,
Figs. S10 and S11). This supports that the Nae moieties are the
primary driving force for the peptoid–DNA interactions as
demonstrated by the MD simulations (Fig. 3). The ζ potential
was also analyzed (n = 3), where bare OCs and PE2- and PE3-
coated OCs were measured at −13.3 ± 0.34, −11.7 ± 0.42, and
−12.6 ± 0.40 mV, respectively. The low ζ potential of OCs was
likely due to the high ionic strength and Mg2+ content of the
buffer, which effectively shielded the surface charge of OCs.
Mg2+ is known to play a central role for the integrity of DNA
origami nanostructures by stabilizing DNA base-pairing and re-
ducing interduplex repulsion (28). Here, an Mg2+-depleted condi-
tion was generated by diluting the bare OCs and peptoid-coated
OCs (OC/peptoid) so that the final concentration of magnesium
chloride (MgCl2) in solution was 1.25 mM (schematic in Fig. 4A).
The structural integrity of OCs was first assessed by AGE. The
peptoid-protected OCs showed bands on the agarose gel similar
to bare OCs, confirming the intact OC nanostructures (SI Ap-
pendix, Fig. S12). However, when MgCl2 concentration was re-
duced from 12.5 to 1.25 mM, a notable electrophoretic band shift
in the agarose gel was observed (Fig. 4 B and C and SI Appendix,
Fig. 4. Analysis of peptoid-coated OCs in low-Mg2+ solution. (A) Schematic view showing peptoid-coated OCs (OC/peptoid) protection against Mg2+ de-
pletion. (B and C) AGE was used to analyze the structural integrity of OCs in TAE buffer at MgCl2 concentrations of 12.5 mM (+) and 1.25 mM (−). In C, the
electrophoretic shift was measured from the reference band at 0.5 kb and the relative value was calculated from that of the control OCs (n = 3). (D) TEM
imaging was performed on OCs extracted from the agarose gels (bands a and b in B). (Scale bars, 200 nm.) D, Insets show magnified images of the OC
structures. (Scale bars, 100 nm.) (E and F) DLS (E) and in situ SAXS (F) spectra for bare OC and OC/PE2 systems treated with EDTA (5 or 10 mM) for 20 to 30 min
at room temperature. a.u., arbitrary units.
Wang et al. PNAS | March 24, 2020 | vol. 117 | no. 12 | 6343
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Fig. S13), indicating the damage of OCs at this ionic condition.
At N/P of 0.5, OC/peptoid showed less electrophoretic shift than
bare OCs, indicating an improved stability in the presence of
peptoids (Fig. 4C). Among the peptoid sequences, OC/PE2
showed the least electrophoretic shift at N/P of 0.5, while the
protection effect was significantly reduced at N/P of 0.1, sup-
porting that higher concentration of positively charged moieties
could compensate the depletion of Mg2+. TEM imaging was
further performed on bare OCs, and OC/peptoid structures were
extracted from the agarose gel. As shown in Fig. 4D and SI
Appendix, Fig. S14A, the structure of bare OCs in a low-Mg2+
condition was significantly distorted and expanded. At an N/P of
0.5, TEM imaging indicated that a dense coating of PE2 did not
compromise the structural integrity of OCs in the Mg2+-depleted
solution (Fig. 4D and SI Appendix, Fig. S14), while the protection
effect was not observed for other peptoid sequences (SI Appendix,
Fig. S15). This stronger PE2–DNA interaction was consistent with
results obtained from the SG assays (Fig. 2).
To probe in-solution structures of the peptoid-coated OCs, we
applied dynamic light scattering (DLS) and in situ small-angle X-
ray scattering (SAXS), which provide an average size of bare OC
and OC/PE2 structures and information about their internal
organization. Here, ethylenediaminetetraacetic acid (EDTA), a
strong metal-ion chelating reagent, was used to remove Mg2+
from the solution, where TEM images showed that the extent of
damaged OCs increased with the increasing concentration of
EDTA (SI Appendix, Fig. S16). As shown in Fig. 4E, DLS
revealed a broadening of a size distribution when the bare OCs
were treated with a high concentration of EDTA (10 mM), in-
dicating a loss of structural integrity of the OCs and increased
heterogeneity of the OC population. On the other hand, peak
broadening was effectively inhibited by PE2 coating, suggesting
that OC stability was significantly improved in the presence of
PE2. Similarly, SAXS showed that the q value at 0.021 Å–1,
representing the form factor of OCs, continued to shift toward
the lower q regime in the presence of EDTA (5 and 10 mM) for
bare OCs, which indicates an overall size increase due to OC
disintegration. In contrast, the structural changes of OCs were
effectively inhibited by PE2 coating (Fig. 4 F and G), with only
some destabilization observed at higher EDTA concentrations.
We note the differences in the scattering profiles at large q for
moderate (5 mM) and high (10 mM) EDTA for bare and OC/
PE2, respectively, indicating that the origin of destabilization was
on the scale of DNA bundles and duplexes. Once the duplexes
were disrupted, the nanoscale structure of origami and its overall
shape might degrade. The flexibility, or “unfoldedness,” of the
Fig. 5. Structural analysis of peptoid-coated OCs in the presence of DNase. (A) Schematic view showing peptoid-coated OCs (OC/peptoid) protected against
DNase I degradation. Adapted with permission from PDB ID: 2DNJ (68). (B) TEM images show bare OC and OC/peptoid structures (N/P: 0.5) in solution
containing DNase I concentration of 15 μg/mL TEM imaging was performed on samples extracted from the agarose gel. (Scale bars, 200 nm.) B, Insets show
magnified images of the OC structures. (Scale bars, 100 nm.)
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OC structures obtained from SAXS were also assessed by using
the Kratky analysis (62). As shown in SI Appendix, Fig. S17, bare
OCs became more flexible and did not plateau at higher q upon
treatment with EDTA, while this effect was inhibited by PE2
coating. These results were consistent with AGE and TEM im-
aging (Fig. 4 B–D and SI Appendix, Fig. S14).
When bare OC and OC/peptoid systems were dispersed in
phosphate-buffered saline (PBS) at lowMg2+ content, all OC/peptoid
exhibited more stable structures compared to those observed in
Tris–acetate–EDTA (TAE) buffer (SI Appendix, Fig. S18). This
was likely due to the Na+ in PBS buffer compensating the loss of
Mg2+ and assisting the stability of OC structures.
To study the ability of OC/peptoid to resist enzymatic degra-
dation, we investigated the OC/peptoid in solution containing
deoxyribonuclease I (DNase I) (schematic in Fig. 5A). As shown
in AGE, bare OCs could be degraded by DNase I at a concen-
tration as low as 2.5 μg/mL, where the increased electrophoretic
mobility suggested a dissociation of staple strands from the OCs
(SI Appendix, Fig. S19). To demonstrate the protecting effect of
peptoids, bare OCs and OC/peptoid were incubated with DNase
I (15 μg/mL) for 30 min at 37 °C and inspected by TEM imaging
(Fig. 5 and SI Appendix, Fig. S20). As expected, bare OC
structures were degraded, and the octahedra shape was damaged
after incubating with DNase I. In the presence of peptoids, the
OC/PE2 structure remained intact, and PE1, PE3, and PE4
showed the ability to preserve the OC structure. DLS also con-
firmed a smaller size reduction of the OC/PE2 at DNase I levels
of 15 and 20 μg/mL compared to bare OCs (SI Appendix, Fig.
S21). We propose that the stronger multivalent interactions in
the OC/PE2 system provides a tighter binding of PE2 and that
hinders DNase I adsorption to both dsDNA and ssDNA motifs,
which significantly reduces the degradation effect of DNase I.
The Nte oligomers of the peptoid sequences are also likely to
provide steric shielding to reduce DNase I binding to the DNA
backbone. To suppress the enzymatic degradation of DNA
nanostructures, the peptoid-coating approach discussed here can
potentially be combined with the denser design of DNA origami
objects, staple routing, and a minimal number of ssDNA frag-
ments (33, 34). At the same time, due to the diversity of nuclease
processes (63), the presented strategy of molecular coating might
be beneficial for the protection of DNA origami of various
designs.
To explore the peptoid-promoted stability of OCs in cell me-
dia, we used PE2 since it has exhibited the best protection in the
experiments discussed above. We investigated OC/PE2 in Dul-
becco’s modified Eagle medium (DMEM) (Fig. 6 C and D and
SI Appendix, Fig. S22) and Roswell Park Memorial Institute
(RPMI) 1640 medium (Fig. 6 A and B) in a low-Mg2+ condition.
TEM images showed that OC/PE2 (N/P: 0.5) were protected
after incubating in both the RPMI and DMEM media at 37 °C
for 24 h, while the OC structures were distorted without PE2
coating (Fig. 6 and SI Appendix, Fig. S22). In the presence of
fetal bovine serum (FBS), the combination of Mg2+ depletion
and FBS nuclease led to enhanced structural damages of bare
OCs beyond recognition (Fig. 6C). On the other hand, TEM
imaging showed the presence of stable OC/PE2 in the DMEM–
FBS medium, although the reduced number of OCs was ob-
served after incubation at 37 °C for 24 h (Fig. 6D). The pro-
tection is expected to be further improved by increasing the
length of the PE2 sequence, enabling stronger peptoid–DNA
interactions while preventing OC aggregation; that requires
further experimentation. In an independent experiment, 10-nm
gold (Au) NPs were encapsulated in the OC structures by surface
functionalization of Au NPs with ssDNAs that complemented
eight ssDNA linkers located in the OCs prior to PE2 coating (SI
Appendix, Fig. S23). As shown in SI Appendix, Fig. S24, the Au
NPs remained encapsulated in the OC/PE2 after incubation in
the DMEM and DMEM–FBS media at 37 °C for 24 h. This
observation further demonstrates that PE2 coating can even
provide protection for nano-cargo that is hybridized inside 3D
origami.
The resistance of OC/PE2 against Mg2+ depletion, change in
buffer component, and nuclease degradation make it an attrac-
tive candidate for biomedical applications of DNA origami. To
this end, we explored the capability of OCs in drug and protein
immobilization and studied their peptoid-enhanced stabilities for
potential applications. We loaded doxorubicin (Dox), a common
anticancer drug used in chemotherapy, to bare OCs and OC/PE2
(N/P: 0.5) and measured its release from the OC structures. Dox-
loaded DNA origamis have been reported in the literature,
where the molecule intercalates the DNA backbone and releases
from the origami structures over time (24–26), but methods to
control its release in time were not established. The intrinsic Dox
fluorescence could be used to measure the loading and release
from the OCs (24–26), where the fluorescence intensity is pro-
portional to the Dox concentration in the submicromolar range
(SI Appendix, Fig. S25). In our case, ∼10% of Dox was loaded
onto the OCs. As shown in SI Appendix, Fig. S26, a reduction
of the total Dox release from the OC/PE2 (∼10% release)
compared to bare OCs (∼30% release) was observed at both
pH 7 and 5.5 after incubating at 37 °C for 48 h in PBS buffer. Such
Fig. 6. The effect of peptoid coating of OCs in cell media and presence of serum nuclease. TEM images show bare OCs (A and C) and PE2-coated OCs (OC/PE2)
(B and D) in RPMI (A and B) and DMEM (C and D) containing 0%, 5%, and 10% FBS and incubated at 37 °C for 24 h. The final concentrations of MgCl2 were
1.25 mM. TEM imaging was performed on samples extracted from the agarose gels. (Scale bars, 200 nm.) A–D, Insets show magnified images of the OC
structures. (Scale bars, 50 nm.)
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ability to modulate the desired release during the drug-delivery
processes can be useful for controlling its biological effect.
We further demonstrated that surface coating of OCs with
PE2 provides protease resistance to proteins encapsulated in the
OC structures. Here, bovine serum albumin (BSA) was modified
with fluorescein and encapsulated in the bare OC and OC/PE2
structures via DNA hybridization (Materials and Methods). The
fluorescence signal was self-quenched due to multiple fluorescein
moieties labeled on a single BSA (64). Fluorescence recovery was
attained in the presence of trypsin, which catalyzed hydrolysis of
BSA preferentially at sites of lysine and arginine (65), and sub-
sequently released the fluorescein-conjugated fragments (sche-
matic in Fig. 7A). In the presence of trypsin, an 85% increase in
the fluorescence intensity was observed in the fluorescein-labeled
BSA in solution (SI Appendix, Fig. S27). This fluorescence en-
hancement representing trypsin digestion of the target BSA se-
quences was reduced to ∼40% by protein encapsulation inside the
OCs and further reduced to ∼14% by PE2 coating on the OC surface
(SI Appendix, Fig. S28). In addition, the fluorescence kinetics assay
showed ∼3× slower trypsin digestion with PE2 coating (Fig. 7B).
Therefore, we believe that peptoid coating can increase protection
of biological cargos inside OCs from solution environments. Note
that higher levels of trypsin (0.1 to 5 μM) in the OC solution were
examined by TEM imaging, and no observable effect on the OC
structures was found (SI Appendix, Fig. S29).
Finally, we anticipated that the peptoid-protected OCs could
be modified with different biological moieties by incorporating
reactive groups into the peptoid sequences. To prove this, two
clickable peptoids (brush and block types, PE8 and PE9) were
synthesized (schematic in Fig. 8A) and used to stabilize OCs.
Azide-Fluor 488 (Sigma) was then conjugated to OCs via copper-
catalyzed click chemistry. As shown in Fig. 8C, the success of
surface conjugation was confirmed by the increased fluorescence
from OCs. We proposed that the peptoid-protected OCs can also
be functionalized with larger biomolecules such as trastuzumab
(Tz), an immunoglobulin G1 monoclonal antibody used to treat
breast cancers that are human epidermal growth factor receptor 2-
positive. To this end, Tz was conjugated with two azide linkers at
the C-terminal formylglycine (fGly) residue of the Tz sequence
prior to peptoid conjugation (66, 67). This allowed us to perform
site-specific antibody–peptoid conjugation via alkyne–azide reac-
tion (SI Appendix, Fig. S30), where the active antibody domains
were presented in an orientated fashion. As shown in Fig. 8D, the
conjugation of Tz on OCs was confirmed by immunogold labeling,
Fig. 7. Protection of protein-encapsulated in OCs by PE2 coating. (A) Schematic view showing that OC/PE2 system reduces trypsin digestion of fluorescein-
labeled BSA encapsulated in the OCs. Adapted with permission from PDB ID: 1S0Q (69). (B) Fluorescence kinetics shows enhanced fluorescence of the
fluorescein-labeled BSA upon trypsin cleavage (λex, 490 nm; λem, 525 nm, 37 °C).
Fig. 8. Surface functionalization of peptoid-stabilized OCs with antibody and fluorophore. (A) Schematic view showing alkyne-modified peptoids conjugates
azide-modified cargos through click chemistry. PE8, Nae–Nprp–(Nae–Nte)10–Nae–Nprp; PE9, Nae6–Nte12–Nprp2, in which prp is the propargyl group. Here,
Azide-Fluor 488 (AF) and Tz were used as the presenting cargos (label 1). (B) Chemical structure of PE8 and PE9. (C) Fluorescence assay of bare OCs, OC/PE8-AF,
and OC/PE9-AF extracted from the agarose gel (λex = 485 nm and λem = 510 to 700 nm). (D) TEM images show surface coating of OCs with PE8-Tz and PE9-Tz.
The samples were labeled with immunogold (label 2 in A) prior to TEM imaging. (Scale bars, 50 nm.)
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where the Tz was stained by Au NP (6 nm)-modified protein G
and visualized by TEM. The Tz-displaying property of OCs can
potentially combine with anticancer drugs to provide a combina-
tory method for cancer therapy.
Conclusion
In this study, we proposed and investigated the use of peptoid
architectures to protect DNA origami in different biological
environments and for drug delivery, imaging, and cell targeting.
Two types (“brush” and “block”) of peptoid architectures were
studied, where the peptoids comprised positively charged (Nae)
moieties and neutral (Nte) moieties. Based on experiments and
MD simulations, we showed the sequence dependency of pep-
toid–DNA interactions, in which brush-type peptoids were ad-
vantageous in stabilizing duplex DNA (dsDNA) by multivalent
interactions across the DNA backbone. Among the peptoid se-
quences, the brush-type PE2 coating on the OCs exhibited the
best protection effect toward OC structures, showing enhanced
stability when challenged by reduced Mg2+ levels or the addition
of nuclease. In addition, the peptoid-coated OCs offered a
controlled release of Dox and protease resistance for protection
of BSA, immobilized inside OCs, from trypsin digestion. Finally,
these peptoids were engineered with one or two alkyne groups
per chain that enabled the display of a fluorophore and an an-
tibody on OC surfaces through click chemistry. The work pre-
sents a systematic study on rationalizing designs of peptoids for
enabling a modular strategy of molecular coatings for DNA ori-
gamis. The study shows that peptoid-coated DNA origami may serve
as a multifunctional fabrication platform for targeted drug delivery,
therapeutics, and sensing.
Materials and Methods
Detailed materials, experimental procedures and characterization com-
pounds, including mass spectrometry, AGE, TEM, DLS, SAXS, and fluorescence
assays, are available in SI Appendix.
Data Availability. All data supporting the findings of this study are available
within this article and SI Appendix or from the corresponding author on
reasonable request.
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